Applied Physics & Chemistry Laboratories, Inc. 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Dec 13, 2018
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
[F1]2018-12-11$21.43/sh−63,504$1,361,157→ 7,398,090 total - Sale
Common Stock
[F2]2018-12-11$22.13/sh−3,253$71,992→ 7,394,837 total - Sale
Common Stock
[F3]2018-12-12$21.21/sh−37,469$794,736→ 7,357,368 total - Sale
Common Stock
[F4]2018-12-13$20.99/sh−29,689$623,166→ 7,327,679 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.055 to $22.05, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.055 to $22.27, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.93 to $21.54, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.83 to $21.28, inclusive.
Signature
/s/ Eva Wen, by power of attorney for Jack Y. Zhang, principal and owner of Applied Physics & Chemistry Laboratories, Inc.|2018-12-13